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Introduction
Necrotizing fasciitis is a generic term for infections of soft
tissue with necrosis. The lesion involves subcutaneous tissue
and superﬁcial fascia and spreads rapidly to involve the deep
fascia. It has been proposed that these conditions including
descending necrotizingmediastinitis (due to dental caries) in
the neck, Fournier’s syndrome in the genitalia, gaseous
gangrene, and fulminant infection with group A hemolytic
Streptococcus (the so-called ‘‘killer bug’’) should be gen-
eralized as skin/soft tissue infections [1, 2].
Pathogenesis
Necrotizing fasciitis is a generic term for infections that
extend rapidly over areolar connective tissue, requiring
treatment of extreme urgency. The major causative
organisms include group A hemolytic Streptococcus,
S. aureus, anaerobic bacteria and intestinal ﬂora. Oral
infection with Vibrio species or Aeromonas species may
also occur. Cases of gas gangrene include those with pri-
mary gas gangrene due to infection with Clostridium spp.
and those with anaerobic infections, i.e., secondary gas
gangrene associated with an underlying disease. Recent
reports have also documented the presence of community-
acquired infection with MRSA. Necrotizing fasciitis usu-
ally occurs in patients who have an underlying disease such
as diabetes mellitus or with trauma or surgical wounds as
the infectious route, but healthy individuals may also suffer
this disease. As inﬂammation progresses, shock may occur,
resulting in necrosis.
Diagnosis
Patients with fulminant group A hemolytic streptococcal
infection may present with pharyngitis symptoms in the
early stage. However, basically, localized rubor, swelling
and circulatory disorder accompanied by severe pain
extend rapidly, and the patient may develop a high fever.
As necrosis progresses, the lesion may exhibit water
blisters, bloody blisters and purplish patches, possibly
resulting in skin necrosis. Infection with gas-forming
bacteria is characterized by a sensation of crushing snow
and crepitation on palpation. The diagnosis is established
when radiography and CT reveal gas patterns. The ﬁnger
test from a small incision shows a characteristic positive
result of easy dissection of the subcutaneous tissue from
the deep fascia. The condition progresses rapidly and the
patient tends to lapse into shock and multiple organ
failure (MOF).
Treatment
Early diagnosis and treatment are pivotal, and the
prognosis depends on the initial care given [2]. The key
treatment points include improvement of general status,
drainage and resection of necrotic tissue, and antibiotic
chemotherapy (Table 1) [1]. Transfer to an emergency
unit with an intensive care unit should be considered if
the patient is in shock. The causative bacterium should
be inferred by gram staining of abscess or necrotic
tissue.
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Surgical treatment
Deep and extensive drainage and resection of necrotic
tissue, as thoroughly as possible, are the mainstays of
surgical treatment. Amputation of an extremity may be
necessary [1–3].
Adjunctive treatment
Patients in shock or with multiple organ failure should
receive advanced life support in intensive care units.
Hyperbaric oxygen therapy has been attempted for gas
gangrene [1].
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Table 1 Antibiotic chemotherapy for necrotizing fasciitis
1. When group A hemolytic streptococcal infection is suspected:
(1) Sulbactam/ampicillin (0.75 or 1.5 g) 3 g per dose, 3 times a day, drip infusion
(2) Piperacillin 2 g per dose, 3–4 times a day, drip infusion
2. When the etiologic agent is unknown (prescription examples):
(1) Imipenem/cilastatin (0.25 or 0.5 g) 1 g per dose, 3–4 times a day, drip infusion, or
(2) Ampicillin (2.0 g per dose, 2–3 times a day, drip infusion) + clindamycin (300 or 600 mg per dose, 2–3 times a day, drip infusion)
Antibiotics are to be altered according to the results of sensitivity tests after identiﬁcation of the etiologic agent
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